BrainAurora Raises HK$500.68 Million Through Share Placing and Top-Up Subscription

The latest announcement is out from BrainAurora Medical Technology Limited ( (HK:6681) ).

BrainAurora Medical Technology Limited has completed a placing of 92 million existing shares at HK$5.60 per share to at least six independent placees, followed by a top-up subscription of an equal number of new shares by the selling shareholder under the company’s general mandate, with no placee becoming a substantial shareholder as a result. The transaction, which closed between 27 January and 5 February 2026, generated approximately HK$500.68 million in net proceeds for the company and slightly adjusted the shareholding structure while maintaining significant stakes by concert parties and core connected persons, reinforcing the company’s capital base and potentially supporting future operational or strategic initiatives.

The most recent analyst rating on (HK:6681) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on BrainAurora Medical Technology Limited stock, see the HK:6681 Stock Forecast page.

More about BrainAurora Medical Technology Limited

BrainAurora Medical Technology Limited is a Hong Kong-listed medical technology company dedicated to developing and commercialising healthcare-related products and services, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 6681. The company operates through a mix of controlling shareholders and other non-public shareholders, with a diversified base of institutional and independent investors in the public float.

Average Trading Volume: 19,548,091

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$5.37B

Find detailed analytics on 6681 stock on TipRanks’ Stock Analysis page.